Country: Belarus
Language: Russian
Source: Министерством здравоохранения Республики (Центр экспертиз и испытаний в здравоохранении)
Skin Tech Pharma Group, S.L., ИСПАНИЯ
изделия медицинского назначения
Skin Tech Pharma Group
2021-11-30
Hyalift ® Repairs · Refills · Stimulates 1014 RRS ® Hyalift ® 35 / RRS ® Hyalift ® 75 / RRS ® Hyalift ® 75 Proactive SKIN TECH PHARMA GROUP SL C/ Pla de l’Estany, 29 17486 Castelló d’Empúries · Girona (SPAIN) www.skintechpharmagroup.com - info@skintechpharmagroup.com Made in Spain w w w . r r s - i n j e c t . c o m 1014 AED_MERRSHya_08_22.06.18 Hyalift ® Hyalift ® Repairs · Refills · Stimulates Repairs · Refills · Stimulates ENGLISH DESCRIPTION · RRS® HYALIFT® 35: Non-cross-linked Hyaluronic Acid 35 mg, class III medical device, made in conformity with Directive 93/42/EEC. · RRS® HYALIFT® 75: Non-cross-linked Hyaluronic Acid 75 mg, class III medical device, made in conformity with Directive 93/42/EEC. · RRS® HYALIFT® 75 PROACTIVE: Non-cross-linked Hyaluronic Acid 75 mg and protective buffer, class III medical device, made in conformity with Directive 93/42/EEC. Hyaluronic Acid is from biotechnological, non animal origin. A medical device can only be injected by legally qualified physician in a legally authorized clinic. PRESENTATION Vials containing 5 ml (0,175 Fl.oz.) - Boxes of 2 vials, 6 vials, 12 vials. Syringes containing 3 ml (0,1 Fl.oz.) - Boxes of 1, 2, 4 syringes. COMPOSITIONS · RRS® HYALIFT® 35 Sodium Hyaluronate 21mg/3ml / 35 mg/5 ml · RRS® HYALIFT® 75 Sodium Hyaluronate 45mg/3ml / 75 mg/5ml · RRS® HYALIFT® 75 PROACTIVE Sodium Hyaluronate 45mg/3ml / 75 mg/5ml Protective buffer 1,54mg/3ml / 2,565 mg/5 ml INDICATIONS · RRS® HYALIFT® 35 Dermal implant for treatment of skin photo ageing and its consequences; treat- ment of dermal atrophy. · RRS® HYALIFT® 75 Dermal implant for treatment of skin photo ageing and its consequences; treat- ment of dermal atrophy. · RRS® HYALIFT® 75 PROACTIVE Dermal implant of Hyaluronic acid for treatment of skin photo ageing and its consequences; treatment of dermal atrophy; HA is solubilized in a protective buffer solution composed by amino acids with hydration and antioxidant properties that stabilize the HA. HOW TO USE The g Read the complete document